Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
48.0%
% of BBH's 27 holdings also in PBE
42.9%
% of PBE's 28 holdings also in BBH
Overlap by Weight
Sector Drift (BBH minus PBE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 10.9% | 5.1% | 5.1% |
|
REGENERON PHARMACEUTICALS | 6.5% | 4.9% | 4.9% |
|
AMGEN INC | 15.3% | 4.7% | 4.7% |
|
ILLUMINA INC | 4.4% | 5.1% | 4.4% |
|
NATERA INC | 4.0% | 5.1% | 4.0% |
Position Highlights (Non-Overlapping Exposures)
BBH Overweight Relative to PBE
|
VERTEX PHARMACEUTICALS INC | 10.8% |
|
AMGEN INC | 10.6% |
|
GILEAD SCIENCES INC | 5.8% |
 |
ARGENX SE ADR | 5.6% |
|
IQVIA HOLDINGS INC | 4.6% |
 |
ICON PLC | 3.5% |
|
ALNYLAM PHARMACEUTICALS INC | 3.3% |
 |
BIONTECH SE SPONSORED ADR | 2.7% |
|
MODERNA, INC. | 2.6% |
|
INSMED INC | 2.2% |
BBH Underweight Relative to PBE
|
UNITED THERAPEUTICS CORP | -5.0% |
|
INCYTE CORP | -3.2% |
|
VERACYTE INC | -2.9% |
|
ACADIA PHARMACEUTICALS INC | -2.9% |
|
BIOCRYST PHARMACEUTICALS INC | -2.9% |
|
CATALYST PHARMACEUTICAL PART | -2.8% |
|
HALOZYME THERAPEUTICS INC | -2.8% |
|
BLUEPRINT MEDICINES CORP. | -2.7% |
|
COLLEGIUM PHARMACEUTICAL, INC. | -2.7% |
|
EXELIXIS INC | -2.7% |